CSIR and Laxai Life Sciences begin phase II trial of niclosamide drug to treat COVID-19
Niclosamide has been extensively used in the past for treating tapeworm infection in adults as well as children
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.